New Street Research - VEON Ltd. Sponsored ADR (VEON) VEON (Buy, TP: $40, +52%) US$100m share buyback announced; delisting from Euronext Amsterdam

Report

New Street Research

Chris Hoare

EUR 8957.00 For Business Accounts Only

VEON (Buy, TP: $40, +52%) US$100m share buyback announced; delisting from Euronext Amsterdam

VEON announced plans to delist from Euronext Amsterdam in 4Q24. It will remain listed on the NASDAQ via ADRs and has announced a share buyback of up to US$ 100m subsequent to the de-listing.

01/08/2024 1 EN

Underlying

VEON Ltd. Sponsored ADR

See profile

US91822M1062 NASDAQ Stock Market United States

Provider

New Street Research

Provided by our team of experienced analysts, our work is idea driven, based on independence of thought, sector expertise, and firmly focussed on fundamentals and valuation.

New Street Research is an independent, partner-owned, research firm specialising in equity and debt research. Our equity research embraces the following sectors:

Pan European Telecom Services and Cable
US Telecoms, Cable, Satellite and Towers
Global Emerging Market Telecoms
Japan Telecoms
Asian Internet
Pan European Healthcare
Global healthcare thematic research

We provide debt research on:

Pan European Telecom Services and Cable

See profile

Analysts

Chris Hoare

Other Reports on these Companies

New Street Research

VEON (Buy, TP: $40, +33%) Feedback from VEON NDR

We hosted VEON in London and New York over the last fortnight. Financing risk has improved materially, and operationally the company continues to perform well in our view.

EUR 8957.00

4h / 31m 4h / 31m 1 EN

New Street Research

VEON (Buy, TP: $40, +48%) Q2 24 Quick Take: Trends still good; guidance reiterated

VEON delivered a good set of numbers, despite some slowdown. Key markets such as Pakistan and Kazakhstan continue to be key drivers while Ukraine improved. ARPU metrics remain good in our view with digital’s share of revenue rising. We do not think bullish medium term guidance are fully reflected in today’s valuation and as such, VEON remains a compelling BUY for us with a US$ 40/ADR price target.

EUR 8957.00

August 8, 2024 August 8, 2024 1 EN

Altice France (Most Preferred) Our take on the latest reported offers

According to recent reports on Bloomberg, an offer has been made from the SSN creditors to Patrick Drahi which is in response to the offer made by Drahi in July.

EUR 8957.00

2h / 7m 2h / 7m 1 EN

Ben Rickett ... (+2)

Ben Rickett
James Ratzer

EU Towers (Cellnex - Neutral, €31, -16%; Inwit - Neutral, €12, +8%) : Rates down, towers up….but is that right?

With interest rates in focus, we take a look at how recent rates moves impact our EU Towers valuations. Consensus wisdom would suggest that falling rates should be positive for towers, but in this short note we challenge that view.

EUR 8957.00

4h / 26m 4h / 26m 1 EN

Chris Hoare

Chris Hoare

VEON (Buy, TP: $40, +33%) Feedback from VEON NDR

We hosted VEON in London and New York over the last fortnight. Financing risk has improved materially, and operationally the company continues to perform well in our view.

EUR 8957.00

4h / 31m 4h / 31m 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

VEON (Buy, TP: $40, +52%) US$100m share buyback announced; delisting from Euronext Amsterdam

VEON (Buy, TP: $40, +33%) Feedback from VEON NDR

VEON (Buy, TP: $40, +48%) Q2 24 Quick Take: Trends still good; guidance reiterated

Altice France (Most Preferred) Our take on the latest reported offers

EU Towers (Cellnex - Neutral, €31, -16%; Inwit - Neutral, €12, +8%) : Rates down, towers up….but is that right?

VEON (Buy, TP: $40, +33%) Feedback from VEON NDR

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe